[Overall survival and survival without local recurrence in case of radiotherapy of the tumor bed of ductal carcinomas in situ of the breast: review of the literature.]

Date publication

janvier 2021

Journal

Gynecologie, obstetrique, fertilite & senologie

Auteurs

Membres identifiés du Cancéropôle Est :
Pr ANTONI Delphine , Pr MATHELIN Carole , Pr NOEL Georges , Pr PIVOT Xavier

Tous les auteurs :
Kuntz L, Fèvre CL, Hild C, Keller A, Gharbi M, Mathelin C, Pivot X, Noël G, Antoni D

Lien Pubmed

https://www.ncbi.nlm.nih.gov/pubmed/33401020

Résumé

Carcinomas in situ represent more than 15 to 20% of breast cancers. Radiotherapy of whole breast is part of the therapeutic standard and follows surgery. However, the indication of tumor bed irradiation is still controversial and heterogeneous according to international practice even though it is a very frequent clinical situation. The aim of this study is to define the indications of tumor bed irradiation in the context of ductal carcinomas in situ and to discuss accelerated partial irradiation of the breast.

Mots clés

Boost, Breast cancer, Cancer du sein, Cancer in situ, Irradiation partielle accélérée, Radiothérapie, accelerated partial breast irradiation, boost, in situ, radiotherapy

Référence

Gynecol Obstet Fertil Senol. 2021 Jan 2;: